Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-17-005478
Filing Date
2017-07-31
Accepted
2017-07-31 07:39:19
Documents
106
Period of Report
2017-07-31

Document Format Files

Seq Description Document Type Size
1 6-K hcm-20170731x6k.htm 6-K 21770
2 EX-99.1 hcm-20170731ex99137e71b.htm EX-99.1 2853102
3 GRAPHIC hcm20170731ex99137e71b001.jpg GRAPHIC 3086
  Complete submission text file 0001558370-17-005478.txt   13811402

Data Files

Seq Description Document Type Size
4 EX-101.INS hcm-20170731.xml EX-101.INS 3959722
5 EX-101.SCH hcm-20170731.xsd EX-101.SCH 83893
6 EX-101.CAL hcm-20170731_cal.xml EX-101.CAL 107294
7 EX-101.DEF hcm-20170731_def.xml EX-101.DEF 247512
8 EX-101.LAB hcm-20170731_lab.xml EX-101.LAB 658321
9 EX-101.PRE hcm-20170731_pre.xml EX-101.PRE 519290
Mailing Address 22ND FLOOR HUTCHISON HOUSE 10 HARCOURT ROAD HONG KONG K3 00000
Business Address 22ND FLOOR HUTCHISON HOUSE 10 HARCOURT ROAD HONG KONG K3 00000 852-2121-3888
Hutchison China MediTech Ltd (Filer) CIK: 0001648257 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: 6-K | Act: 34 | File No.: 001-37710 | Film No.: 17991501
SIC: 2834 Pharmaceutical Preparations